170 related articles for article (PubMed ID: 35671706)
21. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
22. Reproducibility of neuroendocrine lung tumor classification.
Travis WD; Gal AA; Colby TV; Klimstra DS; Falk R; Koss MN
Hum Pathol; 1998 Mar; 29(3):272-9. PubMed ID: 9496831
[TBL] [Abstract][Full Text] [Related]
23. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States.
Shah S; Gosain R; Groman A; Gosain R; Dasari A; Halfdanarson TR; Mukherjee S
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33916960
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients.
Chi Y; Gao S; Du F; Wang JW; Jiang WC; Sun YK; Song Y; He J
Anticancer Drugs; 2016 Jan; 27(1):54-9. PubMed ID: 26398932
[TBL] [Abstract][Full Text] [Related]
27. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
28. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
[TBL] [Abstract][Full Text] [Related]
29. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Hayes AR; Luong TV; Banks J; Shah H; Watkins J; Lim E; Patel A; Grossman AB; Navalkissoor S; Krell D; Caplin ME
J Neuroendocrinol; 2022 Oct; 34(10):e13184. PubMed ID: 36121922
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of typical and atypical lung carcinoids.
Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract][Full Text] [Related]
32. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
[TBL] [Abstract][Full Text] [Related]
33. Recent advances and current controversies in lung neuroendocrine neoplasms
Metovic J; Bianchi F; Rossi G; Barella M; Sonzogni A; Harari S; Papotti M; Pelosi G
Semin Diagn Pathol; 2021 Sep; 38(5):90-97. PubMed ID: 33810912
[TBL] [Abstract][Full Text] [Related]
34. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
36. Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study.
Marciello F; Mercier O; Ferolla P; Scoazec JY; Filosso PL; Chapelier A; Guggino G; Monaco R; Grimaldi F; Pizzolitto S; Guigay J; de Latour BR; Giuffrida D; Longchampt E; de Montpreville VT; Fadel E; Colao A; Planchard D; Papotti M; Faggiano A; Baudin E
Neuroendocrinology; 2018; 106(3):264-273. PubMed ID: 28813709
[TBL] [Abstract][Full Text] [Related]
37. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
Prinzi N; Rossi RE; Proto C; Leuzzi G; Raimondi A; Torchio M; Milione M; Corti F; Colombo E; Prisciandaro M; Cascella T; Spreafico C; Beninato T; Coppa J; Lo Russo G; Di Bartolomeo M; de Braud F; Pusceddu S
Clin Lung Cancer; 2021 May; 22(3):161-169. PubMed ID: 33618994
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature.
Hermans BCM; Derks JL; Moonen L; Habraken CHJ; der Thüsen JV; Hillen LM; Speel EJM; Dingemans AC
Lung Cancer; 2020 Dec; 150():152-158. PubMed ID: 33171403
[TBL] [Abstract][Full Text] [Related]
40. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
Travis WD
Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
